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Abstract
Objectives—Inferring the pain level of a critically ill infant is complex. The ability to accurately
extract the appropriate pain cues from observations is often jeopardized when heavy sedation and
muscular blocking agents are administered. Near-infrared spectroscopy (NIRS) is a noninvasive
method that may provide the bridge between behavioral observational indicators and cortical pain
processing. We aimed to describe regional cerebral and systemic hemodynamic changes, as well
as behavioral reactions in critically ill infants with congenital heart defects (CHD) during chest
drain removal following cardiac surgery.
Methods—Our sample included 20 critically ill infants with CHD less than 12 months of age
admitted to the cardiac intensive care unit following surgery.
Results—Cerebral deoxygenated hemoglobin concentrations significantly differed across the
epochs (i.e. Baseline, Tactile stimulus, Noxious stimulus) (p = .01). Physiological systemic
responses and FLACC pain scores differed significantly across the events (p < .01). The three
outcome measures were not found to be associated with each other. Mean FLACC pain scores
during the painful procedure was 7/10 despite administration of morphine. Midazolam
administration accounted for 36% of the variance in pain scores.
Discussion—We demonstrated with a multidimensional pain assessment approach that
significant cerebral, physiological and behavioral activity was present in response to a noxious
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Figure S1. Mean changes in left hemisphere [HbO2] across events in males (n = 12) and females (n = 8). Vertical bars denote the
standard deviations and the middle points denote the mean values. T0: baseline; T1: tactile stimulation; T2: noxious stimulation.
Figure S2. Mean changes in right hemisphere [HbO2] across events in males (n = 11) and females (n = 8). Vertical bars denote the
standard deviations and the middle points denote the mean values. T0: baseline; T1: tactile stimulation; T2: noxious stimulation.
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procedure in critically ill infants despite the administration of analgesic treatment. Considering
that the sedating agent significantly dampened pain behaviors, assessment of cerebral
hemodynamic in the context of pain seems to be an important addition.
1. Introduction
To appropriately respond and treat pain in the non-communicative child, one must be able to
accurately extract the appropriate pain cues from observations. Although a wide variety of
pain measures exist for assessing pain in non-communicative infants and children, no one
measure has been uniformly accepted. Although a considerable body of knowledge now
exists, an observational tool that evaluates pain with sound validity, reliability, specificity,
and sensitivity remains elusive (1). More recently, researchers have directed their efforts
towards improving the psychometric properties of existing pain assessment instruments
within various populations, types of pain and contextual factors (2). Clinicians still do not
know if the behaviors they observe are specific to pain or if they are manifestations of other
experiences such as agitation, distress, fear, stress, or sadness (1;3). This issue is even more
problematic when dealing with critically ill infants, in which the expressive capacity is often
jeopardized by the administration of heavy sedation and muscular blocking agents.
Most of the available paediatric pain assessment instruments are multidimensional,
incorporating both behavioral (facial action, body movement, cry) and physiological (heart
rate, respiratory rate, blood pressure, arterial oxygen saturation) indicators. Dissociation
between these two classes of indicators has been reported with an average correlation of 0.3
(4–6). Behavioral measures, especially facial actions, are more likely to respond selectively
to pain (7), while physiological indicators change in response to painful stimuli, but also for
numerous reasons not specific to pain (5;8;9).
Hemodynamic and electrical brain studies into pain processing show potential for exploring
these issues (10–12;14–16). One such approach employs continuous near-infrared
spectroscopy (NIRS), which may provide the bridge between behavioral observational
indicators and cortical pain processing, thus serving as an alternative and perhaps more
specific instrument in the measure of pain in critically ill infants. In fact, recent studies in
premature and term infants indicated that painful stimuli cause hemodynamic changes in
specific cortical regions of the brain (11;14;16).
In this study we report on regional cerebral and systemic hemodynamic changes, as well as
behavioral reactions in critically ill infants with congenital heart disease (CHD) during a
routine painful procedure. We assessed the cerebrovascular and cardiovascular responses to
postoperative chest-drain removal by means of continuous NIRS as well as usual monitoring
of heart rate, systemic blood oxygenation, and mean arterial blood pressure. Behavioral
reactions were also captured through video recordings and rated for pain retrospectively
with the Face Leg Activity Cry Consolability (FLACC) pain scale. Specifically, we
examined differences within subjects across phases of the procedure, factors associated with
the response (sex, age, weight, and medication), as well as associations between cerebral
hemodynamic changes, systemic physiological changes, FLACC pain scores and specific
clinical variables.
1.1. Research questions
The following research questions guided this study:
1. Is a noxious stimulation associated with regional cerebral hemodynamic changes of
critically ill infants as measured with NIRS?
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2. Do regional cerebral hemodynamic (as measured with NIRS), physiological (vital
signs) and behavioural (as measured with FLACC scale) reactions significantly
correlate in response to a noxious stimulation in critically ill infants?
2. Materials and Methods
2.1. Study population
Forty infants less than 12 months who required a surgical procedure for repair of a CHD and
who required a chest drain post-operatively were prospectively recruited between April 2009
and May 2010. We excluded infants who were diagnosed with a spinal or peripheral nervous
system illness. The research protocol was approved by the Institutional Review Board at
Children’s Hospital Boston, USA. We obtained parental written informed consent in all
cases, and 89% of the approached parents gave their consent.
2.2. Instrumentation
The infants’ cerebral hemodynamic and associated physiological signals, as well as video
recordings were continuously monitored and recorded for approximately 30 minutes
surrounding the chest drain removal.
A non-invasive NIRS-based tissue oxygenation monitor (NIRO 300, Hamamastu Photonics,
Japan) was used to measure changes in cerebral tissue oxygenation. This NIRS device has
two channels, each consisting of an emitting and a receiving optode. When possible, the
emitter optode was positioned approximately 2 cm beneath and slightly posterior to the C3/
C4 position (according to the international EEG 10–20 system (14;17)); the receiver optode
was positioned 4 cm apart from the emitter optode allowing illumination of the primary
somatosensory cortex and possibly the underlying structures. When this optode
configuration was not possible due to hair coverage, which causes interference with the laser
signal, or other obstacles (i.e. intravenous indwelling catheter), optodes were placed in the
frontoparietal or temporoparietal regions. Optodes were placed in a flexible rubber holder
that prevented interference from external light sources and kept the distance between the
emitter and receiver optodes constant at 4 cm.
The cerebral oxygenation signal obtained with the NIRS technique is based on the
absorption of near-infrared light by hemoglobin, which in turn depends on the oxygenation
state of hemoglobin circulating through the tissues. The NIRS technology employed in this
study does not measure the absolute cerebral concentrations in oxygenated hemoglobin
([HbO2]) and deoxygenated hemoglobin ([HbH]), but rather absolute change in
concentration from an unknown reference value (17–19). This method has been described in
a recent review paper (20). The NIRS device allows for data sampling at 6 Hz.
The systemic arterial oxygen saturation (SaO2), the electrocardiogram (ECG), and arterial
blood pressure were recorded continuously from the patient’s bedside monitor (Philips
Intellivue MP70, Andover, MA). An indwelling arterial line placed either in the femoral or
radial arteries provided continuous monitoring of the arterial blood pressure waveform, from
which mean arterial blood pressure (MAP) was computed on a beat-by-beat basis.
2.2.1. Face Leg Activity Cry Consolability (FLACC) scale—The FLACC scale is a
unidimensional behavioral pain assessment instrument to measure pain in young children in
the post-operative period (21). It includes five items (Face, Leg, Activity, Cry, and
Consolability) and has good inter-rater reliability (Kappa 0.52–0.82), as well as good
content and convergent validity (21). The FLACC has been shown to be reliable in critically
ill young children (22;23).
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2.3. Data collection
The analogue signals were passed through a band-pass filter and a notch filter at 60 Hz. The
band-pass filter was used for anti-aliasing, and the notch filter to exclude potential 60 Hz
artifact common in the intensive care unit (ICU) setting. During measurement recording,
cerebral, systemic physiological data, and video were simultaneously transferred to a
portable user interface monitor (Component Neuromonitoring System, Day One Medical,
LLC, Ambler PA, USA). This device is a computer-based system that continuously records,
displays, stores, and analyzes in real-time physiological data from multiple monitoring
sources in real-time, allowing data synchronization, display, and analysis.
Equipment set-up and data acquisition were completed by the same study investigator (MR),
except on one occasion. The investigator was continuously present during the data-
acquisition process to document in the patient’s study file the precise beginning and end of
the chest-drain removal procedure and steps leading to the actual noxious stimulation, as
well as the nature of all other events (e.g. study events, administration of medication,
handling by care provider or parent, etc.) that occurred throughout the study.
2.4. Chest-drain removal procedure
Data collection was carried out in the cardiac intensive care unit (CICU) at the bedside of
the patient, and the nurses performing the chest-drain removal were asked to carry out the
procedure as usual. No interruption on the part of the study investigator took place. Once the
equipment was set up, baseline data were gathered prior to the noxious procedure to allow
calibration of NIRS device and adjustments for artefacts. Each procedure was performed
according to a standardized care plan. The chest-drain removal procedure comprised a
sequence of steps and a variety of sensory stimuli, including: (1) administration of
analgesics and/or sedatives (e.g. morphine and/or midazolam) in the majority of the cases,
(2) removal of dressing, (3) untying of purse-string sutures around the exit site, (4) removal
of the drain at the height of expiration, and (5) pulling tightly on the purse string to allow
closure of the exit site, immediately followed by application of a pressure bandage.
Data analysis was divided into three 30-second intervals (epochs); these were precisely
marked during recordings by the study investigator on an Excel event log sheet. Once the
procedure was completed, all recordings were stopped and the equipment was removed.
2.5. Data selection
Three 30-second epochs that represent quiet baseline (T0), tactile stimulation (T1) (removal
of dressing), and removal of chest drain (T2), respectively were documented. The baseline
(T0) period during which the infant was calm and not disturbed was captured at
approximately 20 to 25 minutes prior to the drain removal. About 5 minutes prior to the
removal of the chest drain, a period of tactile stimulation (T1) which was defined by removal
of the dressing and preparation of the procedure took place. The epoch corresponding to the
noxious stimulus response (T2) was signaled by the unit nurse as soon as the tube began to
be pulled on peak expiration by the patient.
2.5.1. Video—Filmed behavioral displays were rated according to the recommended
procedure for clinical use of the FLACC scale by a clinical nurse specialist (CNS) in
paediatric pain experienced with the use of the instrument and blinded to the purpose of the
study. The footages were played back in real time on a personal computer; each of the 30-
second segments previously identified by study investigator (MR) was coded for pain scores
by the CNS. Thus, the blinded coder generated three pain FLACC scores related to the study
epochs, and this for each participant (Cronbach alpha of 0.8). This same procedure was
repeated ten weeks after the first ratings were done to test intrarater reliability of 0.9
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intraclass correlation coefficient (ICC). A second blinded CNS in paediatric pain coded half
of the sample to establish interrater reliability of 0.86 (0.71–0.96) (ICC).
2.6. Data pre-processing and statistical analysis
For ease of data handling, the physiological signals were subsequently down-sampled to 20
Hz prior to further analysis. From the raw data we computed average [HbO2], [HbH], HR,
MAP, and SaO2 values for each 30-second epoch. For ease of naming, each variable will be
referred to by its name without mentioning “mean”. We also computed average changes for
each signal (Δ[HbO2], Δ[HbH], ΔHR, ΔMAP, and ΔSaO2) between the different event
epochs: Tactile vs. Baseline (T1–T0), Noxious vs. Baseline (T2-T0), and Noxious vs. Tactile
(T2-T1).
A custom Matlab script was used to process the raw recordings and analyze the data (Matlab
Student version 7.0, The Mathworks, Natick, MA). To determine whether chest-drain
removal procedures induced statistically significant cerebral and systemic hemodynamic
changes compared to the other epochs, a repeated measure ANOVA was conducted to
compare [HbO2], [HbH], HR, MAP, and SaO2 responses, as well as FLACC pain scores
between the epochs. Sex was added as a between-subject factor. Univariate linear regression
analyses were used to verify associations between changes in NIRS signal values (Δ[HbO2]
and Δ[HbH]), systemic physiological responses (ΔHR, ΔMAP, ΔSaO2), FLACC pain score
changes, analgesic medication doses, age, weight, pediatric risk of mortality score (PRISM
III) (24), and elapsed time since surgery of chest- drain removal.
Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS)
version 15.0 (IBM, Somers, NY); p-values of less than 0.05 were considered significant, and
Bonferroni correction was used to adjust for multiple comparison. Mauchly’s test was used
to verify the assumption of sphericity, and if violated, degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity.
3. Results
3.1. Population
The families of 45 infants were approached in the pre-operative cardiac clinic to participate
in the study. Forty infants were enrolled, and 32 (18 males; 14 females) participated in the
immediate post-operative period. Eight recruited participants were not recorded because
chest drain removal was missed (n = 6) or the patient was transferred to another unit prior to
procedure (n = 2). Although all 32 infants were filmed, we were able to capture good quality
video recordings of the procedure to enable behavioral pain coding in only 20 infants (12
males; 8 females). These participants comprised the sample for the present study, though not
all 20 recorded data sets could be used in the analysis due to equipment issues, loss of
signal, or excessive noise in the recordings. Twenty NIRS data sets for left hemisphere and
19 for right hemisphere were analyzed, 20 for HR, and 18 for SaO2. Fourteen infants had an
indwelling arterial catheter allowing for continuous MAP monitoring. Infants’
characteristics are presented in Table 1.
The 20 infants underwent cardiopulmonary bypass for various CHD. Seven children had a
co-morbid condition with the most common being Trisomy 21 in five patients (3 females; 2
males), one had a connective tissue disorder and one had a syndrome associated with digital
abnormality not well characterized otherwise. During chest-drain removal, 35% of the
participants were supported by a conventional ventilator (n = 6) or continuous positive
airway pressure (CPAP) (n = 1). Cortical somatosensory placement of optodes was not
achieved in six participants because of hair or access issues. In these 6 cases, optodes were
placed in the frontotemporal and temporoparietal regions.
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3.2. Cerebral NIRS changes
In response to chest drain removal, significant increases in regional cerebral deoxygenated
hemoglobin concentrations [HbH] were found. Specifically, the right hemisphere [HbH]
differed significantly between the different 30-second epochs F(2, 36) = 5.07 (p = .01).
Within-subject pairwise comparisons showed significant differences between Baseline (T0)
and Noxious (T2) [HbH] (p = .04) in the right hemisphere (Figure 1). We found no
significant changes in the left hemisphere [HbH] or bilateral cerebral regional oxygenated
hemoglobin [HbO2]. Optode placement or chest tube location were not determining factors
in cerebral hemodynamic responses.
3.3. Systemic physiological changes
In response to chest-drain removal, we found significant increases in systemic mean arterial
blood pressure (MAP). MAP differed significantly between the different 30-second epochs
F(1.38, 16.52) = 19.18 (p < .001). Within-subject pairwise comparisons showed significant
differences between the three 30-second epochs: T2 and T0 MAP (15.75 CI [6.62, 24.89]; p
= .001); T2 and T1 MAP (p = .005); T0 and T1 MAP (p = .012).
Heart rate (HR) differed significantly between the different 30-second epochs F(1.28, 24.27)
= 6.87 (p = .01). Within-subject pairwise comparisons showed significant differences
between T2 and T0 HR (11.35 CI [1.27, 21.42]; p = .02). No other significant differences
were found; systemic arterial blood oxygenation (SaO2) level was not found to differ
significantly across the 30-second epochs.
3.4. FLACC pain scores
Mean FLACC pain scores at the three epochs were 0.25 (SD 0.12); CI [0.01, .51] at
baseline, at tactile 3.25 (SD 0.56); CI [2.08, 4.23], and at noxious 6.7 (0.66); CI [5.32, 8.08].
Overall, FLACC pain scores differed significantly between the different 30-second epochs
F(1, 19) = 102.64 (p < .001) (Table 2; Figure 2). Female infants had significantly higher
FLACC scores than males F(1, 18) = 9.65 (p = .006) across all events. In addition to the
standard pharmacological treatment, two participants received sucrose prior to chest-drain
removal and both had 9/10 FLACC pain scores in response to the noxious procedure.
3.5. Changes in NIRS, physiological signals and pain scores across 30-second epochs
We performed univariate analyses to explore the association among study parameters related
to changes (Δ) observed during the different 30-second epochs, as well as exploring the
relationship between these and clinical factors. Table 3 shows those relationships that
achieved statistical significance on univariate analysis. Only left hemisphere Δ[HbO2] was
associated with ΔHR, explaining 32% of the change. No other NIRS signal change across
the three 30-second epochs was found to be significantly correlated with physiological
signals. Total FLACC pain scores and its five indicators were not significantly associated
with the NIRS and physiological signal changes across the different epochs.
In response to chest-drain removal, infants with the comorbid condition Trisomy 21 did not
differ significantly in their cerebral and physiological hemodynamic response or FLACC
pain scores when compared to the rest of the sample. Infants’ age and weight significantly
correlated with some of the measured variables. Results from the univariate analyses are
found in Table 3.
3.5.1. Effects of medication—The administration of analgesic medication (morphine)
was significantly associated with less changes in [HbO2] (β −137.78, p = .005) and [HbH]
(β −82.54, p = .002). Morphine doses also decreased the response in HR (β −90.24, p = .
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022). The administration of analgesic was not significantly associated with FLACC pain
scores changes.
Sedation medication administration (midazolam) was associated with significantly less
changes in left hemisphere [HbO2] and bilateral [HbH] (β −114.87, p = .017; β −63.7, p = .
015; β −137.49, p = .008). Midazolam doses also significantly decrease the responses of the
HR and SaO2 (β −146.63, p = .005; β −71.27, p = .012). Administration of a sedative was
significantly correlated with less FLACC pain scores changes between T0 and T2 (−65.76; p
= .005) and 19% of the changes between T0 and T1 (−40.53; p = .05). These data are
presented in Table 3.
3.5.2. Individual changes between T2-T0—For comparison purposes, we divided the
sample in two groups: (1) the moderate to severe pain group (FLACC pain scores ≥ 5) and
(2) the no pain to mild pain group (FLACC pain scores ≤ 4). For the first group, mean
FLACC scores were 8/10, mean cerebral hemodynamic (i.e. [HbO2] and [HbH]) varying
from −0.6 to 4.7 µmol/l with large standard deviations, and smaller mean doses of morphine/
midazolam. The second group received higher mean doses of these same drugs with lower
mean FLACC scores 2/10, and mean cerebral hemodynamic changes between −0.33 to 3.3
µmol/l. These results can be found in the supplemental Tables S1 and S2 which show the
results of the descriptive analyses of individual cerebral hemodynamic and FLACC score
changes from baseline to chest-drain removal.
3.6. Sex disparity
Sex of the patient was found to be a determining factor in the cerebral and behavioral
responses (supplemental Figures S1 and S2). Females responded more strongly than males
across the events in the right hemisphere [HbO2] F(1, 17) = 4.3 (p = .05). As stated
previously, female infants had significantly higher pain scores across the events as well
(Figure 2). We found that the change in FLACC scores of males from T0 to T2 was
significantly dampened by the midazolam administered doses (β = −70.43, CI [−134.43,
−6.43], p = .03; r(11) = −0.61). This was not the case in female infants.
4. Discussion
We demonstrated varying cerebrovascular and systemic hemodynamic changes, as well as
pain behavioral manifestations in response to chest-drain removal in critically ill infants
with CHD following open heart surgery. We demonstrated the gender differences: females
showed significantly stronger cerebral hemodynamic response and higher pain scores across
the events when compared to males. Finally, we failed to find significant associations
between these three multidimensional “pain” parameters.
Previous studies that have reported on cerebral hemodynamic responses to noxious stimuli
have focused on preterm and term born neonates (11;14;16). These studies showed
significant bilateral mean increases in [HbO2] (14) or in the maximum change in the
contralateral total hemoglobin concentrations ([HbT] = [HbO2] + [HbH]) (11;16) when
compared to baseline. None of these studies reported on the measured changes in the [HbH]
or incorporated pharmacological treatment for pain into their analyses, therefore making
comparison with our findings difficult. Regional cerebral activation typically results in
regional increases in both [HbO2] and [HbT] with a decrease in [HbH] (25). However,
contrasting results have been reported, including no change or increases in [HbH] with
increases in both [HbO2] and [HbT] (26–28).
To date, there is only one study reporting on associations between pain scores and cerebral
hemodynamic responses in infants. In twelve preterm and term neonates (measured on 33
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occasions), Slater et al. (11) found moderate correlations (r = .57; p = .001) between scores
of a multidimensional pain scale (Premature Infant Pain Profile- PIPP (29)) and maximum
change in the contralateral [HbT] in response to heel lance. Moreover, they showed that the
cortical response had a stronger association with the behavioral components of the PIPP (i.e.
facial expression) compared with the physiological components (i.e. HR and SaO2 changes
from baseline) (r = .4; p = .04). Although some correlations between the behavioral FLACC
pain scores and cerebral hemodynamic responses were present in our study, they did not
attain statistical significance. However, this is most certainly due to lack of power since in
order to attain a statistically significant correlation between any of these signals, a minimal
association of 0.55 was needed. Similar to our finding, Gelinas et al. (30) did not find
significant associations between behavioral pain scores, adult patient’s self-report, and
regional cerebral oxygenation (rSO2) during nociceptive procedures, although taken
individually, these parameters did show significant changes from their baseline measure.
Recently Frank et al. (31), recommended that the COMFORT (32) pain scale be used as the
main pain assessment instrument for recognizing post-operative and procedural pain in the
critically ill neonate when compared to three other tools. The COMFORT scale was best at
identifying analgesic effectiveness. This composite pain assessment instrument may be more
suitable for critical care contexts where significant clinical factors (e.g. inotropes, ventilator
support, etc) can impact pain measures (31). The FLACC scale, not designed specifically for
this population, is not sensitive enough to these and other factors.
Experimental findings have consistently demonstrated that women experience pain more
intensely than men do (33–35). Nonetheless, the lower pain scores found in male infants in
our study population could be explained by the significant impact (i.e. r = −.61) that
midazolam had on their behavioral manifestations when compared to females; thus
dampening males’ capacity to express their pain experience. The exact mechanism
underlying this gender difference and the role of midazolam calls for further investigations
with a larger sample to insure reproducibility of these findings. As many physiological,
structural, hormonal, psychological, and environmental factors influence how the human
brain responds to noxious stimulation, whether and how these explain the gender differences
in brain activation that we found would require a much larger sample size than was available
in our study (36).
Although we expected some level of pain in response to chest-drain removal, we did not
anticipate the mean FLACC pain scores to be severe (7/10) since nearly all infants (n = 19)
received an analgesic. Additionally, the sedating agent’s (midazolam) ability to blunt/
dampen the behavioral response to pain should be taken into account when conducting pain
evaluations solely on the basis of behavioral manifestations. Although cerebral
hemodynamics responses were decreased by pharmacological treatments, changes in [HbO2]
and [HbH] irrespective of hemisphere were still present in the infants with lower FLACC
pain scores (e.g. FLACC 1/10 with Δ[HbO2] Left, Right = 6.32, 1.12 and Δ[HbH] Left,
Right = 7.29, 3.79 µmol/l). Thus, adding cerebral measurements to a behavioral assessment
may complement the pain evaluation when there is a risk of dampened behaviors, e.g.,
highly sedated or paralyzed patients. These data underscore the need for further
investigations of pain responses in non-communicative patients which combine
simultaneous cerebral and behavioral assessment.
A recent study by Slater et al. (10) demonstrated that neonates were still showing
somatosensory neuronal activity after receiving sucrose, a treatment known to be effective
for reducing procedural pain response (37), even though their behavioral pain scores were
significantly lowered. The effectiveness of this widely used non-pharmacological pain
treatment was questioned, but the validity of the behavioral pain measure was not
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questioned. This discrepancy stresses the importance of assessing the two dimensions of
pain (38–40): the sensory dimension as reflected by somatosensory hemodynamic activity
and the emotional dimension as reflected by behavioral manifestations. Each dimension may
be more differentially sensitive to non-pharmacological and pharmacological treatments.
This again emphasizes the necessity of using a multidimensional approach to completely
capture the pain experience, especially in non-verbal critically ill populations.
Several limitations of our study are apparent. First or foremost, our sample size limited the
extent of our analyses and conceivably our ability to obtain statistically significant
associations between cerebral hemodynamic changes and behavioral pain scores.
Additionally, we could not perform multivariate statistical tests which would have allowed
us to describe more precisely interactions between our variables and possibly important
clinical indicators. Second, optode placement and consistent interrogation of the same brain
regions is a major concern with NIRS. Currently multichannel NIRS devices that cover
multiple regions of the scalp are not readily available but their use in adult and older
children functional NIRS research is increasing in popularity (25;41–44).
Controlling for movement artefact and possible confounding environmental factors in this
clinical research, although very difficult, represents an additional limitation to the study.
However, since the purpose of this research was to explore, through the use of NIRS
technology, cerebral hemodynamic changes to a frequently performed noxious procedure in
critically ill patients, we wanted to capture changes in a routine clinical setting. For this
reason, we elected not to interfere with standard care and apply a more strict control over
possible confounding factors.
Although understanding of the multidimensional experience of pain has advanced over the
last century, avenues remain unexplored, particularly in vulnerable populations such as the
non-communicative patients. Near-infrared spectroscopy has potential as a technique for
assessing pain evoked cerebral activation in critically ill infants. Given the complexity of
NIRS technology and known limitations (20), at his stage it may be best to consider this
neurodiagnostic technique solely as a research tool. Through further research, we will
improve our understanding of pain perception, increase the psychometric features of
currently available pain assessment instruments, and perhaps assess the efficacy of
pharmacological and non-pharmacological treatments. Determining what constitutes a
clinically significant change in the measured parameters (i.e. [HbO2], [HbH], and [HbT])
when compared with normal fluctuations that occur in the brain tissue by sampling both
healthy and critically ill infants of differing developmental ages is also needed. Therefore,
setting standards for specific use in pain measurement could facilitate the generalization of
findings.
A major question that is raised by clinicians caring for non-communicative patients is
whether this technique will move beyond research to become a bedside monitoring
technique for pain assessment. Moreover, can this technology help us monitor the cerebral
hemodynamic changes due to prolonged pain versus acute procedural pain, and can it make
this distinction. When looking at the research findings and current available devices, this
may seem improbable. Nevertheless, this approach should not be abandoned since its
usefulness as a portable means to functional brain mapping is evolving well and setbacks are
being resolved (41–42).
Using a multidimensional pain assessment approach, we demonstrated that significant
cerebral, physiological and behavioral activity was present in response to a noxious
procedure in critically ill infants despite the administration of analgesic treatment. The fact
that the average FLACC scores were high and that the sedative agent, rather than analgesic
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treatment, reduced the pain ratings significantly may urge health-care professionals to
question current pain management protocols during chest-drain removal in critically ill
infant. Despite low pain scores in some infants, this group still showed relatively high
cerebral hemodynamic activity in response to chest-drain removal. Hence, there is additional
information from brain activity in these circumstances. Dampened behaviors by a sedating
agent during a procedure known to be painful may jeopardize the discriminate validity of
certain behavioral cues. This is especially relevant when heavy sedation and/or blocking
agents are administered. Further research using an approach that combines cerebral and
behavioral evaluation is warranted.
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Figure 1.
Changes in right hemisphere [HbH] values in all subjects (n = 19). The figure shows
significant [HbH] increases from baseline (T0) to noxious stimulation (T2) *p < 0.05.
Vertical bars denote the standard deviations and the middle points denote the mean values.
T0: baseline; T1: tactile stimulation; T2: noxious stimulation.
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Figure 2.
Mean FLACC pain scores for baseline (T0), tactile (T1), and noxious (T2) events between
males (n = 12) and females (n = 8). The figure shows significant differences in overall
FLACC scores across the three events (p < 0.001) and between males and females (p <
0.01).
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Table 1
Demographic and clinical characteristics of our cohort (N= 20)
Mean age (months) 3.7 ±1.4; range 1.5–7
Mean weight (Kg) 5.5 ±1.6; range 2.8–10
Mean PRISM III scores 8.5 ± 3.9; range 3–18
Diagnosis: TOF (+ pulmonary stenosis)
      VSD &VSD/PFO
      ASD/VSD
      CAVC
      Combination of 2 or more
      Other
n = 7
n = 5
n = 3
n = 1
n = 2
n = 2
Mean morphine dose mg/kg/dose 0.05; range 0.0–0.2 (median 0.05)
Mean midazolam dose mg/kg/dose 0.04; range 0.0–0.1 (median 0.05)
Mean time from surgery at noxious procedure 32.9 hours; range 16–96 (median 24.5)
Location of chest drain Midline (n= 16)
Right (n= 4)
Type of chest drain Chest tube (n = 2); Blake drain (n = 18)
Mean maximum pain score in last 24h (n = 18) 4.5/10; range 0–7
PRISM III: Pediatric RISk of Mortality; TOF: Tetralogy of Fallot; VSD: Ventricular septal defect; ASD: Atrial septal defect; PFO: Patent foramen
ovale; PDA: Patent ductus arteriosis; CAVC: Complete Atrioventricular Canal; Combination: VSD/ASD/PDA, CAVC/TOF; Other: Aortic root
aneurysm, hypoplastic left heart syndrome, Transitional AV canal; pain score was taken from patients’ charts.
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Table 2
FLACC pain scores regression analysis (n = 20)
Epochs Mean difference 95% CI p-value
T1-T01 3.00 [1.49, 4.51] < .001
T2-T02 6.45 [4.65, 8.25] < .001
T2-T13 3.45 [1.65, 5.25] < .001
1
For Tactile stimulation - Baseline
2
For Chest-drain removal - Baseline
3
For Chest-drain removal - Tactile stimulation
T0 baseline; T1 tactile stimulus; T2 noxious stimulation (chest-drain removal).
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